Pediatrix Medical Group, Inc. (NYSE:MD) Receives Average Recommendation of "Hold" from Brokerages

Key Points

• Analyst consensus is “Hold”: Five of seven brokerages rate Pediatrix Medical Group neutral, while two recommend buying. The average 12-month price target is $24.33, below the stock’s reported opening price of $26.07.
• Quarterly results exceeded expectations: Pediatrix reported earnings of $0.63 per share versus the $0.59 consensus estimate, while revenue reached $487.78 million, up 4.1% year over year and above forecasts.
• Institutional ownership remains high: Institutional investors own 97.71% of the company, while insiders hold 1.80%; a director recently sold 36,028 shares for approximately $855,665.

Shares of Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) have earned an average recommendation of "Hold" from the seven brokerages that are covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $24.3333.

A number of research analysts recently weighed in on MD shares. Mizuho set a $24.00 price objective on Pediatrix Medical Group in a research report on Friday, May 8th. UBS Group increased their target price on Pediatrix Medical Group from $22.00 to $25.00 and gave the company a "neutral" rating in a research note on Tuesday, May 12th. Truist Financial upped their price target on Pediatrix Medical Group from $23.00 to $28.00 and gave the company a "hold" rating in a report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a $25.00 target price on shares of Pediatrix Medical Group in a research report on Wednesday. Finally, Jefferies Financial Group reissued a "buy" rating and set a $27.00 price objective on shares of Pediatrix Medical Group in a report on Monday, April 20th.

Pediatrix Medical Group Stock Performance

Shares of MD stock opened at $26.07 on Thursday. The company's fifty day moving average price is $24.85 and its 200-day moving average price is $22.56. The stock has a market cap of $2.14 billion, a PE ratio of 12.47 and a beta of 0.66. The company has a current ratio of 2.19, a quick ratio of 1.33 and a debt-to-equity ratio of 0.66. Pediatrix Medical Group has a 12 month low of $12.95 and a 12 month high of $27.94.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.59 by $0.04. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. The company had revenue of $487.78 million during the quarter, compared to analysts' expectations of $478.49 million. During the same period last year, the company posted $0.53 EPS. Pediatrix Medical Group's revenue was up 4.1% on a year-over-year basis. On average, equities analysts expect that Pediatrix Medical Group will post 2.1 EPS for the current fiscal year.

Insider Activity

In related news, Director Shirley A. Weis sold 36,028 shares of Pediatrix Medical Group stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $23.75, for a total value of $855,665.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.80% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Pediatrix Medical Group

A number of large investors have recently made changes to their positions in the company. Keybank National Association OH boosted its stake in shares of Pediatrix Medical Group by 2.0% during the 1st quarter. Keybank National Association OH now owns 22,941 shares of the company's stock worth $491,000 after purchasing an additional 458 shares during the period. Gotham Asset Management LLC lifted its stake in Pediatrix Medical Group by 0.6% in the third quarter. Gotham Asset Management LLC now owns 116,093 shares of the company's stock worth $1,945,000 after purchasing an additional 724 shares during the last quarter. ProShare Advisors LLC boosted its position in shares of Pediatrix Medical Group by 4.6% during the fourth quarter. ProShare Advisors LLC now owns 16,816 shares of the company's stock valued at $360,000 after buying an additional 734 shares during the period. Verition Fund Management LLC grew its stake in shares of Pediatrix Medical Group by 4.4% during the third quarter. Verition Fund Management LLC now owns 25,408 shares of the company's stock valued at $426,000 after buying an additional 1,066 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its stake in shares of Pediatrix Medical Group by 77.7% during the 1st quarter. EverSource Wealth Advisors LLC now owns 2,515 shares of the company's stock worth $54,000 after acquiring an additional 1,100 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc NYSE: MD is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source